Inhibition of cell growth and induction of apoptosis in non-small cell lung cancer cells by delta-tocotrienol is associated with notch-1 down-regulation

Journal of Cellular Biochemistry

Volumn 112, Issue 10, 2011, Pages 2773-2783

  Ji, Xiangming ^a   Wang, Zhiwei ^b   Geamanu, Andreea ^a   Sarkar, Fazlul H ^b   Gupta, Smiti V ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

apoptosis; delta tocotrienol; lung carcinoma; NF B; Notch 1

Indexed keywords

DELTA TOCOTRIENOL; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NOTCH1 RECEPTOR; PROTEIN BCL XL; SURVIVIN; TOCOPHEROL; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, NOTCH1; VITAMIN E;

EID: 80053188650     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23184     Document Type: Article

References (35)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ,. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
2. Bigas A, Martin DIK, Milner LA,. 1998. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol Cell Biol 18: 2324-2333. (Pubitemid 28152679)
3. Buchler P, Gazdhar A, Schubert M, Giese N, Reber HA, Hines OJ, Giese T, Ceyhan GO, Muller M, Buchler MW, Friess H,. 2005. The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg 242: 791-800 discussion 800-791.
4. Constantinou C, Hyatt JA, Vraka PS, Papas A, Papas KA, Neophytou C, Hadjivassiliou V, Constantinou AI,. 2009. Induction of caspase-independent programmed cell death by vitamin E natural homologs and synthetic derivatives. Nutr Cancer 61: 864-874.
5. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha S, Miele L, Bocchetta M,. 2010. Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathway. Oncogene 29: 2488-2498.
6. Espinosa L, Cathelin S, D'altri T, Trimarchi T, Statnikov A, Guiu J, Rodilla V, Ingles-Esteve J, Nomdedeu J, Bellosillo B, Besses C, Abdel-Wahab O, Kucine N, Sun SC, Song G, Mullighan CC, Levine RL, Rajewsky K, Aifantis I, Bigas A,. 2010. The Notch/Hes1 pathway sustains NF-kappaB activation through CYLD repression in T cell leukemia. Cancer Cell 18: 268-281.
7. Guo D, Ye J, Dai J, Li L, Chen F, Ma D, Ji C,. 2009. Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res 33: 678-685.
8. Hussein D, Mo H,. 2009. d-Dlta-tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells. Pancreas 38: e124-e136.
9. Itoh M, Fu L, Tohda S,. 2009. NF-kappaB activation induced by Notch ligand stimulation in acute myeloid leukemia cells. Oncol Rep 22: 631-634.
10. Ju J, Picinich SC, Yang Z, Zhao Y, Suh N, Kong AN, Yang CS,. 2010. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 31: 533-542.
11. Jundt F, Anagnostopoulos I, Forster R, Mathas S, Stein H, Dorken B,. 2002. Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99: 3398-3403. (Pubitemid 34525322)
12. Karin M,. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436. (Pubitemid 44050137)
13. Kumar KS, Raghavan M, Hieber K, Ege C, Mog S, Parra N, Hildabrand A, Singh V, Srinivasan V, Toles R, Karikari P, Petrovics G, Seed T, Srivastava S, Papas A,. 2006. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci 78: 2099-2104.
14. Lin JT, Chen MK, Yeh KT, Chang CS, Chang TH, Lin CY, Wu YC, Su BW, Lee KD, Chang PJ,. 2010. Association of high levels of Jagged-1 and Notch-1 expression with poor prognosis in head and neck cancer. Ann Surg Oncol 17 (11): 2976-2983.
15. Mcanally JA, Jung M, Mo H,. 2003. Farnesyl-O-acetylhydroquinone and geranyl-O-acetylhydroquinone suppress the proliferation of murine B16 melanoma cells, human prostate and colon adenocarcinoma cells, human lung carcinoma cells, and human leukemia cells. Cancer Lett 202: 181-192. (Pubitemid 37485891)
16. Miele L, Golde T, Osborne B,. 2006. Notch signaling in cancer. Curr Mol Med 6: 905-918. (Pubitemid 44883940)
17. Miele L, Osborne B,. 1999. Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 181: 393-409. (Pubitemid 29513408)
18. Mumm JS, Kopan R,. 2000. Notch signaling: From the outside in. Dev Biol 228: 151-165. (Pubitemid 32011983)
19. Nickoloff BJ, Osborne BA, Miele L,. 2003. Notch signaling as a therapeutic target in cancer: A new approach to the development of cell fate modifying agents. Oncogene 22: 6598-6608. (Pubitemid 37372340)
20. Ohishi K, Katayama N, Shiku H, Varnum-Finney B, Bernstein ID,. 2003. Notch signalling in hematopoiesis. Semin Cell Dev Biol 14: 143-150. (Pubitemid 36315881)
21. Oswald F, Liptay S, Adler G, Schmid RM,. 1998. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol 18: 2077-2088. (Pubitemid 28152657)
22. Oswald F, Tauber B, Dobner T, Bourteele S, Kostezka U, Adler G, Liptay S, Schmid RM,. 2001. p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol 21: 7761-7774. (Pubitemid 32988785)
23. Reedijk M, Odorcic S, Zhang H, Chetty R, Tennert C, Dickson BC, Lockwood G, Gallinger S, Egan SE,. 2008. Activation of Notch signaling in human colon adenocarcinoma. Int J Oncol 33: 1223-1229.
24. Shibata A, Nakagawa K, Sookwong P, Tsuduki T, Tomita S, Shirakawa H, Komai M, Miyazawa T,. 2008. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha. J Nutr 138: 2136-2142.
25. Shih Ie M, Wang TL,. 2007. Notch signaling, gamma-secretase inhibitors, and cancer therapy. Cancer Res 67: 1879-1882.
26. Shin HM, Minter LM, Cho OH, Gottipati S, Fauq AH, Golde TE, Sonenshein GE, Osborne BA,. 2006. Notch1 augments NF-kappaB activity by facilitating its nuclear retention. EMBO J 25: 129-138. (Pubitemid 43077302)
27. Shirode AB, Sylvester PW,. 2010. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling. Biomed Pharmacother 64: 327-332.
28. Sylvester PW, Kaddoumi A, Nazzal S, El Sayed KA,. 2010. The value of tocotrienols in the prevention and treatment of cancer. J Am Coll Nutr 29: 324S-333S.
29. Sylvester PW, Shah S,. 2005. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Asia Pac J Clin Nutr 14: 366-373. (Pubitemid 43219093)
30. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, Mattson MP, Furukawa K,. 2004. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci U S A 101: 9458-9462. (Pubitemid 38812896)
31. Wang Z, Banerjee S, Li Y, Rahman KM, Zhang Y, Sarkar FH,. 2006a. Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 66: 2778-2784.
32. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH,. 2006b. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 106: 2503-2513. (Pubitemid 43787677)
33. Wang Z, Zhang Y, Li Y, Banerjee S, Liao J, Sarkar FH,. 2006c. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 5: 483-493.
34. Westhoff B, Colaluca IN, D'ario G, Donzelli M, Tosoni D, Volorio S, Pelosi G, Spaggiari L, Mazzarol G, Viale G, Pece S, Di Fiore PP,. 2009. Alterations of the Notch pathway in lung cancer. Proc Natl Acad Sci U S A 106: 22293-22298.
35. Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Marsh CB, Otterson GA, Nana-Sinkam SP,. 2009. MicroRNAs in the pathogenesis of Lung Cancer. J Thorac Oncol 4: 1028-1034.